PLM for Pharma & Life Sciences

PharmOptimaEnjen AI

Formulation to release — one trail.

Validated PLM. Auditable by design.

Formula and CMC management, stability data, validation workflows, and regulatory documentation — unified with batch operations and 21 CFR Part 11 controls baked in.

21 CFR Part 11native compliance< 30 dCMC change-cycle median100%electronic signatures audit-ready

Book a PLM walkthrough See capabilities

Pharma lifecycle

How pharma products move through Enjen.

Stage names re-tuned to match how your operations actually run.

Stage 1 / 8

Concept

Ideation, briefs, and viability — captured in one place.

Capabilities

Built for the way pharma actually works.

Formula & CMC Management

Manage active/excipient ratios, in-process specs, and CMC dossier sections in one structured system.

Multi-strength and multi-pack family management
Side-by-side compare across formulation revisions
CMC dossier sections (3.2.P) auto-assembled from spec data

Stability & Shelf-Life

Run stability protocols (ICH Q1A) with auto-scheduled pull points, results capture, and trend analysis.

Long-term, accelerated, and intermediate study tracking
Out-of-trend alerts before specifications are breached
Shelf-life recommendation engine with statistical justification

Validation Workflows

IQ/OQ/PQ for equipment and process validation with versioned protocols and signed-off reports.

Risk-based validation scoping (ICH Q9)
Linked deviations and CAPA across studies
Re-validation triggers from change-control events

Supplier Qualification

Qualify API and excipient suppliers with audit calendars, GMP certifications, and re-qualification triggers.

Track GMP / ISO certifications and expiries
Risk scoring on quality-event history
Auto-flag spec drift across vendor lots

Compliance heatmap

Compliance, mapped to how the system actually works.

Compliance shouldn't be a project you tack on — it should be how the system works. Here's how Enjen PLM maps to the frameworks regulated manufacturers actually face.

NativeConfigPartner

"We cut our CMC change-cycle from 90 days to 23. The formulation, stability, and supplier change all moved through one workflow — no more email forwarding between QA, RA, and manufacturing."

Head of Regulatory AffairsBengaluru-based life sciences manufacturerResult: 74% faster CMC change cycle; zero observations in next FDA inspection.

Business Impact

What Pharma customers see.

Directional ranges from active deployments — your actuals will depend on baseline and scope.

< 30 d

Median CMC change cycle

40–60%

Reduction in deviation investigations

100%

Audit-ready electronic batch records

90%+

CAPA closure within SLA

Watch

See Enjen PLM run a pharma operation

A walkthrough of Enjen — how an AI-native platform handles formulation, validation, and batch release in regulated pharma environments.

FAQ

Common questions about PLM for Pharma

Answers to what pharma buyers ask most often.

What is PLM for pharmaceutical manufacturers?

PLM for pharma manages the full chemistry, manufacturing, and controls (CMC) lifecycle of a drug product — from formulation and master recipe through validation, stability data, electronic batch records, and post-market changes. It links specifications, regulatory documentation, and manufacturing execution under a single audit-ready chain.

How does PLM differ from a pharmaceutical ERP?

ERP runs the financial and operational backbone — inventory, procurement, batch costing, dispatch. PLM owns the product master: formulae, specs, master recipes, change control, validation, and stability. The two systems must converge: a CMC change in PLM should immediately propagate to MRP planning, costing, and supplier requalification in ERP.

How long does it take to deploy pharma PLM with Enjen?

Typical deployment is 10–14 weeks. Configured pharma templates for 21 CFR Part 11, electronic signatures, EBR, and CMC change control are pre-loaded. Implementation includes formulae migration, master recipe rebuild, role mapping, and validation execution.

Is Enjen PLM compliant with 21 CFR Part 11 and GMP?

Yes. Electronic signatures, audit trails, time-stamped records, role-based access, and validation lifecycle support are native. Validation deliverables (URS, FS, DS, IQ, OQ, PQ) are included for FDA, CDSCO, and EMA inspections. GxP controls cover all critical workflows.

Can it handle multi-site formulation transfers and tech transfer?

Yes. Tech transfer workflows, parallel manufacturing site approvals, and effectivity dating across plants are built in. The same master recipe can have site-specific overrides while maintaining a single regulatory record.

What ROI do pharma manufacturers typically see?

Customers report 40–60% fewer deviation investigations, 30–50% faster batch release cycles, and a median 9-month payback. The biggest gains usually come from collapsed CMC change cycles and audit-ready records eliminating manual compliance prep.

Resources